Rivastigmine API Manufacturers

compare suppliers & get competitive offers

Filters

Reset

Selected filters:

Type
Production region
Qualifications
Country of origin

HIGHLIGHTED

Located in:

Slovakia

Produced in:

Slovakia

Established in: 1941

MOQ: -

Employees: 600+

Pilot plant & cGMP Kilolab

Human API & Veterinary API EU GMP

API and FDF production, API R&D & CDMO

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • KDMF

  • CEP

  • DMF

  • GMP

  • CoA

Contact supplier

Replies quickly

Produced in:

Unknown

Established in: 1963

MOQ: -

Employees: 800+

World’s 1st exclusive API distributor

Portfolio of 600+ APIs

>250 clients in Europe

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • CoA

  • MSDS

Contact supplier

Replies quickly

Produced in:

China

Established in: 2011

MOQ: 10 g

Employees: 10+

Fast Response and Good Communication

Willingness To Start From Small

Flexible Payment Terms

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • BSE/TSE

  • CoA

  • MSDS

Contact supplier

Replies can take a few days

Located in:

Italy

Producer

Produced in:

United States

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • CoA

Contact supplier

Replies slower than most

Located in:

Iceland

Produced in:

Unknown

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Contact supplier

Replies slower than most

Located in:

Spain

Producer

Produced in:

Spain

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • CoA

Contact supplier

Replies slower than most

Located in:

India

Producer

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Located in:

India

Producer

Produced in:

Unknown

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • CEP

  • DMF

  • JDMF

  • WC

  • CoA

  • KDMF

Located in:

India

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • WC

  • CoA

  • DMF

Located in:

Sweden

Produced in:

Sweden

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • DMF

  • FDA

  • CEP

  • coa

Located in:

Italy

Producer

Produced in:

Italy

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • JDMF

  • CoA

  • GMP

Located in:

India

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • FDA

  • CEP

  • DMF

  • WC

  • coa

Located in:

India

Producer

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • WC

  • CoA

  • GMP

Located in:

India

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • WC

  • CoA

  • GMP

How does it work?

1
Register for free
icon

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

2
Start sourcing
icon

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

3
Send inquiries
icon

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

4
Get quotation
icon

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

5
Arrange agreement
icon

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Rivastigmine API 123441-03-2?

Description:
Here you will find a list of producers, manufacturers and distributors of Rivastigmine. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Rivastigmine 
Synonyms:
Ena 713 Free Base  
Cas Number:
123441-03-2 
DrugBank number:
DB00989 
Unique Ingredient Identifier:
PKI06M3IW0

About Rivastigmine

What can you use it for? Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.

Ask the supplier for a certificate of analysis to find out more about the quality of Rivastigmine.

Rivastigmine is a type of Cholinesterase inhibitors


Cholinesterase inhibitors are a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a crucial role in the treatment of various medical conditions. These compounds work by inhibiting the activity of the enzyme cholinesterase, which breaks down the neurotransmitter acetylcholine in the body.

Acetylcholine is involved in many important processes in the central and peripheral nervous systems, including muscle contractions, memory, and cognitive functions. By inhibiting cholinesterase, these APIs help to increase the levels of acetylcholine in the brain and enhance cholinergic neurotransmission.

Cholinesterase inhibitors have proven to be highly effective in the management of Alzheimer's disease, a progressive neurodegenerative disorder characterized by cognitive decline and memory loss. These APIs, such as donepezil, rivastigmine, and galantamine, are commonly used as symptomatic treatments to alleviate cognitive impairment and enhance patients' overall quality of life.

Furthermore, cholinesterase inhibitors find applications beyond Alzheimer's disease. They are also utilized in the treatment of other conditions, including Parkinson's disease, glaucoma, myasthenia gravis, and certain types of dementia.

The development and utilization of cholinesterase inhibitors have revolutionized the treatment options for patients suffering from these debilitating disorders. As research in neuroscience and pharmacology advances, the continuous refinement of cholinesterase inhibitors and the discovery of novel compounds within this subcategory hold promise for future therapeutic breakthroughs.


Rivastigmine (Cholinesterase inhibitors), classified under Central Nervous System Agents


Central Nervous System (CNS) Agents are a crucial category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that specifically target the central nervous system. The CNS encompasses the brain and spinal cord, playing a vital role in regulating and controlling various bodily functions, including cognition, movement, emotions, and sensory perception. These agents are designed to interact with specific receptors, enzymes, or ion channels within the CNS to modulate neural activity and restore normal functioning.

CNS agents comprise a diverse range of pharmaceutical APIs, including analgesics, anesthetics, antipsychotics, sedatives, hypnotics, anti-epileptics, and antidepressants. Each subcategory addresses distinct neurological disorders and conditions. For instance, analgesics alleviate pain by targeting receptors in the brain and spinal cord, while antipsychotics are employed to manage psychosis symptoms in mental illnesses such as schizophrenia.

The development of CNS agents involves rigorous research, molecular modeling, and extensive clinical trials to ensure safety, efficacy, and specific target engagement. Pharmaceutical companies invest significant resources in identifying novel drug targets, synthesizing new compounds, and optimizing their pharmacological properties. These agents undergo rigorous regulatory evaluations and must adhere to stringent quality standards and guidelines.

Given the prevalence of CNS disorders globally, the market demand for effective CNS agents is substantial. The development of innovative CNS APIs not only improves patient outcomes but also provides valuable commercial opportunities for pharmaceutical companies. Continued advancements in CNS agent research and development hold the promise of groundbreaking therapies that can improve the quality of life for individuals affected by neurological conditions.



Rivastigmine manufacturers | traders | suppliers

We have 14 companies offering Rivastigmine produced in 8 different countries.

Get in contact with the supplier of your choice:

  • Saneca Pharma from Slovakia, product country of origin Slovakia
  • TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
  • Shandong Octagon Chemicals Limited from China, product country of origin China
  • Cambrex from Italy, product country of origin United States
  • Actavis Group from Iceland, product country of origin Unknown
  • Infar, S.A. from Spain, product country of origin Spain
  • Cipla from India, product country of origin India
  • Mylan from India, product country of origin Unknown
  • Jubilant Generics from India, product country of origin India
  • Cambrex, Karlskoga from Sweden, product country of origin Sweden
  • Erregierre from Italy, product country of origin Italy
  • MSN Organics from India, product country of origin India
  • Sun Pharma from India, product country of origin India
  • Hetero Drugs from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.